Product Information
ABSORICA 20 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $35.7441 per EA under NDC 10631011631. Its NADAC has been published 331 times since Nov 28, 2013.
FDA first approved this application on May 25, 2012. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631011631
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
ISOTRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA021951FDA Approved
5/25/2012
TE Code
AB2
On Market Since
6/8/2012
Pharmacological Classes
Price Statistics
The NADAC for ABSORICA 20 MG CAPSULE has been published 331 times since Nov 28, 2013, and over the history we have for it it has risen 68.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $35.7441 per EA |
|---|---|
| All-time high | $35.7441 (Aug 19, 2026) |
| All-time low | $21.2100 (Nov 28, 2013) |
| 52-week high | $35.7441 |
| 52-week low | $35.3489 |
| Median price | $30.4824 |
| Average price | $30.0238 |
| Largest weekly change | +16.8% (Apr 17, 2024) |
| Weeks tracked | 331 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ABSORICA 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ABSORICA 20 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $35.7441 per EA (NDC 10631011631), effective Aug 19, 2026.
How has the price of ABSORICA 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ABSORICA 20 MG CAPSULE has risen 68.5%. It has been tracked across 331 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABSORICA 20 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ABSORICA 20 MG CAPSULE has ranged from a low of $21.2100 (Nov 28, 2013) to a high of $35.7441 (Aug 19, 2026), with a median of $30.4824 per EA.
Are there cheaper alternatives to ABSORICA 20 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMNESTEEM 20 MG CAPSULE, is $1.8613 per EA — about 95% below ABSORICA 20 MG CAPSULE.
Who manufactures ABSORICA 20 MG CAPSULE?
ABSORICA 20 MG CAPSULE (NDC 10631011631) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.